Nanoviricides Stock Alpha and Beta Analysis
| NNVC Stock | USD 1.19 0.01 0.83% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as NanoViricides. It also helps investors analyze the systematic and unsystematic risks associated with investing in NanoViricides over a specified time horizon. Remember, high NanoViricides' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to NanoViricides' market risk premium analysis include:
Beta 0.16 | Alpha (0.11) | Risk 6.26 | Sharpe Ratio (0.01) | Expected Return (0.09) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
NanoViricides | Build AI portfolio with NanoViricides Stock |
NanoViricides Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. NanoViricides market risk premium is the additional return an investor will receive from holding NanoViricides long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in NanoViricides. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate NanoViricides' performance over market.| α | -0.11 | β | 0.16 |
NanoViricides expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of NanoViricides' Buy-and-hold return. Our buy-and-hold chart shows how NanoViricides performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.NanoViricides Market Price Analysis
Market price analysis indicators help investors to evaluate how NanoViricides stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NanoViricides shares will generate the highest return on investment. By understating and applying NanoViricides stock market price indicators, traders can identify NanoViricides position entry and exit signals to maximize returns.
NanoViricides Return and Market Media
The median price of NanoViricides for the period between Mon, Sep 29, 2025 and Sun, Dec 28, 2025 is 1.42 with a coefficient of variation of 15.15. The daily time series for the period is distributed with a sample standard deviation of 0.21, arithmetic mean of 1.42, and mean deviation of 0.16. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
About NanoViricides Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including NanoViricides or other stocks. Alpha measures the amount that position in NanoViricides has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
NanoViricides Upcoming Company Events
As portrayed in its financial statements, the presentation of NanoViricides' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NanoViricides' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of NanoViricides' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of NanoViricides. Please utilize our Beneish M Score to check the likelihood of NanoViricides' management manipulating its earnings.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with NanoViricides
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out NanoViricides Backtesting, NanoViricides Valuation, NanoViricides Correlation, NanoViricides Hype Analysis, NanoViricides Volatility, NanoViricides History and analyze NanoViricides Performance. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
NanoViricides technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.